Ticker
ARVNCompany Name
ARVINAS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Free Cash Flow | Free Cash Flow to Debt | Total Liabilities |
---|---|---|---|
6/30/2025 | $ -399M | 0 | $ 300M |
3/31/2025 | $ -252.7M | 0 | $ 341M |
12/31/2024 | $ -261M | 0 | $ 529.7M |
9/30/2024 | $ -259.8M | 0 | $ 581.1M |
6/30/2024 | $ -217M | 0 | $ 679.4M |
3/31/2024 | $ -356M | 0 | $ 602.9M |
12/31/2023 | $ -350.7M | 0 | $ 644.6M |
9/30/2023 | $ -339.8M | 0 | $ 601.1M |
6/30/2023 | $ -322.7M | 0 | $ 619.9M |
3/31/2023 | $ -313.4M | 0 | $ 664.8M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF / Liabilities
(=) FCF/D
FCF/D for ARVINAS INC is calculated as follows: FCF [ $ -83.3M ] / Liabilities [ $ 66.83M ]
(=) FCF/D [ 0 ]
Minimum
Jun 30, 2022
Maximum
Sep 30, 2021
Average
Median
filtered constituents | 2.25K |
---|---|
min | 0 |
max | 0.47 |
average | 0.11 |
median | 0.09 |
std | 0.1 |